marijuana stocks

NTRR Executives Investigate New Opportunities at Premier U.S. Cannabis Industry Event

As Neutra Corp. (NTRR) prepares for the launch of its state-of-the-art inhalant delivery system, CEO Chris Brown and other company executives are examining potential new opportunities and partnerships at the 2014 Marijuana Business Conference & Expo in Las Vegas, the premier networking event in the cannabis industry.

With NTRR’s innovative Diamond Anvil Vapor Pen set for its first commercial production run, the Expo provides NTRR an exciting opportunity to explore potential deals as over 2,000 cannabusiness professionals and 125-plus exhibitors from in excess of 30 U.S. states and 10 countries are in attendance.

“The U.S. cannabis industry has tremendous momentum, and we are poised to capitalize on it with the innovations we are preparing to bring to the market,” NTRR CEO Chris Brown said. “We have had a number of discussions about our Diamond Anvil Vapor Pen with major industry investors at the Expo, and the demand for our innovation is readily apparent. We are very excited about the potential revenues the Diamond Anvil Vapor Pen can return.”

The Diamond Anvil Vapor Pen is a state-of-the-art inhalation delivery system that can be used with a suite of products, from dry herbs to concentrates to oils. The portable personal vaporizer also features customizable amplitude settings for different nutraceutical products.

The surging U.S. cannabis market has inspired NTRR to partner with up-and-coming innovators in a large ancillary market that is also benefitting fast-growing legalized cannabis industry. Alongside Vertigo Technologies, Diamond Anvil Designs and Surface to Air Solutions, the company is working to deliver powerful, practical breakthroughs in the indoor cultivation and delivery of cannabis and other nutraceuticals.

About Neutra Corp.

Neutra Corp. (NTRR) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), Terra Tech Corp. (TRTC) and ENDEXX Corp (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MDBX Founder Comments on Affiliate Sales of Stock

Medbox Founder Comments on Affiliate Sales of Stock Founder clarifies that sales…

Reliq Health Technologies Inc. (RQHTF) Announces Go Live with Comprehensive Partners, LLC in Florida

Reliq Health Technologies, Inc. Announces Go Live with Comprehensive Partners, LLC in…

GW Pharmaceuticals plc (GWPH) Announces Acceptance of NDA Filing for Epidiolex®

GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the…

Cronos Group Inc. (CRON) to Hold 2020 Third Quarter Earnings Conference Call on November 5, 2020

Cronos Group Inc. to Hold 2020 Third Quarter Earnings Conference Call on…